Business & Regulation

Download our eBook to find out how the industry is trying to be more sustainable.

An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?

The first Humira biosimilar in the US is here, but market penetration could be a challenge.

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

Our priorities paint a picture of who we are, and that’s as true in RNAi medicine development as it is elsewhere in life

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Applied correctly, data can do almost anything

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

It’s a fact that the pharma industry is dominated by white men. What does this mean for people from different ethnic backgrounds?